Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)
Becton Dickinson (BDX) reported Total Non-Current Liabilities of $24.2 billion for Q1 2026, down 52.91% year-over-year from $51.5 billion in Q1 2025, and down 55.02% quarter-over-quarter from $53.9 billion in Q4 2025.
Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Total Non-Current Liabilities data on file, last reported at $24.2 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $24.2 billion, down 52.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.2 billion (down 52.91% YoY), and the FY2025 annual result was $27.3 billion, down 27.36% from the prior year.
- Total Non-Current Liabilities declined to $24.2 billion in Q1 2026 per BDX's latest filing, from $53.9 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $56.1 billion in Q2 2022 and troughed at $24.2 billion in Q1 2026.
- A 5-year average of $41.4 billion and a median of $49.4 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities soared 84.2% in 2024, then tumbled 52.91% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $32.9 billion in 2022, then dropped by 14.49% to $28.1 billion in 2023, then soared by 84.2% to $51.8 billion in 2024, then gained by 4.03% to $53.9 billion in 2025, then slumped by 55.02% to $24.2 billion in 2026.
- Business Quant data shows BDX's Total Non-Current Liabilities at $24.2 billion in Q1 2026, $53.9 billion in Q4 2025, and $27.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 2.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24 Bn |
| Dec 31, 2025 | 53.88 Bn |
| Sep 30, 2025 | 27.30 Bn |
| Jun 30, 2025 | 26.60 Bn |
| Mar 31, 2025 | 51.47 Bn |
| Dec 31, 2024 | 51.80 Bn |
| Sep 30, 2024 | 37.59 Bn |
| Jun 30, 2024 | 51.42 Bn |
| Mar 31, 2024 | 50.41 Bn |
| Dec 31, 2023 | 28.12 Bn |
| Sep 30, 2023 | 49.75 Bn |
| Jun 30, 2023 | 28.96 Bn |
| Mar 31, 2023 | 34.36 Bn |
| Dec 31, 2022 | 32.88 Bn |
| Sep 30, 2022 | 49.37 Bn |
| Jun 30, 2022 | 56.10 Bn |
| Mar 31, 2022 | 49.45 Bn |
| Dec 31, 2021 | 34.10 Bn |
| Sep 30, 2021 | 29.39 Bn |
| Jun 30, 2021 | 56.03 Bn |